Skullcap for Anti-Inflammatory

Research suggests that skullcap and its key bioactive flavonoids — particularly baicalin, baicalein, and wogonin — demonstrate meaningful anti-inflammatory activity across a range of experimental contexts, with studies consistently showing suppression of inflammatory cytokines, inhibition of enzymes like COX-1, COX-2, and 5-LOX, and reduction of oxidative stress markers. The body of evidence reviewed here consists predominantly of in vitro cell studies, animal models, and narrative reviews, with one clinical trial finding that flavocoxid, a baicalin-containing nutraceutical, performed comparably to naproxen in managing osteoarthritis knee symptoms with a more favorable side effect profile. Studies indicate that these anti-inflammatory mechanisms may have relevance across diverse conditions, including cardiovascular injury, metabolic disease, allergic responses, periodontal disease, and reproductive health, though most findings remain at the preclinical stage. A significant limitation across this literature is the near-total absence of rigorous human clinical trials, meaning that while the mechanistic evidence is promising and directionally consistent, its translation to therapeutic use in people has not yet been established.